Delaware Health Information Network (DHIN) and Pathology Lab Partner with iSpecimen to Bring COVID-19 Specimens to Researchers

Delaware Health Information Netwok (DHIN) and Pathology Lab partners with iSpecimen® to bring COVID-19 specimens to researchers. Through the iSpecimen Marketplace, medical researchers can now access a new daily source of biospecimens from patients who have recently taken COVID-19 tests and consented to release their de-identified data.

Read details

> you might also like:

Webinar 3: Equitable Distribution of COVID-19 Vaccines

September 22, 2021

Event Summary and Key Takeaways: Ensuring equitable delivery of COVID-19 vaccines has had many complexities, tasking leaders to face both hard decisions and to be creative in producing solutions. The...

Center for Value in Health Care Publishes Drug Rebates Analysis

September 9, 2021

CIVHC published new analysis on prescription drug rebates finding that prescription drug spending and rebates for both brand and specialty drugs are rising rapidly in Colorado.

Washington Health Alliance Releases 2020 eValu8 Report

September 9, 2021

Washington Health Alliance recently issued their 2020 eValue8™ report. This is the nation’s leading evidence-based request for information (RFI) tool used to assess the quality of health plans. The eValue8™...

Delaware Health Information Network (DHIN) and Pathology Lab Partner with iSpecimen to Bring COVID-19 Specimens to Researchers

Share: